The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, Kidney Int, vol.57, pp.74-81, 2000. ,
DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States, Blood Purif, vol.22, issue.1, pp.175-80, 2004. ,
, National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, vol.39, issue.2, pp.1-266, 2002.
Kidney disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement, Nephrol Dial Transplant, vol.28, pp.1346-59, 2013. ,
, Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group: KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int, pp.279-335, 2012.
, Kidney Disease: Improving Global Outcomes (KDIGO) Work Group: 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int, vol.3, issue.1, pp.1-150, 2013.
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis, Circulation, vol.119, issue.5, pp.671-680, 2009. ,
Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS, Kidney Int, vol.64, pp.254-62, 2003. ,
Dialysis Outcomes and Practice Patterns Study: Données sur l'utilisation des cathéters veineux centraux en hémodialyse chronique, Nephrologie, vol.22, pp.379-84, 2001. ,
Type of vascular access and mortality in U.S. hemodialysis patients, Kidney Int, vol.60, pp.1443-51, 2001. ,
Higher catheter use within facilities is associated with increased mortality and hospitalization. Results from the DOPPS, J Am Soc Nephrol, vol.299, p.12, 2001. ,
Health status as a potential mediator of the association between hemodialysis vascular access and mortality, Nephrol Dial Transplant, vol.29, issue.4, pp.892-900, 2013. ,
DOPPS estimate of patient life years attributable to modifiable haemodialysis practices in Belgium, Acta Clin Belg, vol.62, issue.2, pp.102-112, 2007. ,
Estimación, según el estudio DOPPS, de los años de vida de pacientes atribuibles a las prácticas de hemodiálisis modificables en España, Nefrología, vol.27, issue.4, pp.496-504, 2007. ,
Gain de vie potentiel pour les patients hémodialysés français attribuable aux modifications des pratiques et la mise en conformité avec les cibles recommandées: une estimation permise par l'étude DOPPS, Néphrol Thér, vol.4, issue.4, pp.256-65, 2008. ,
Dialysis Outcomes and Practice Patterns Study estimate of patient life-years attributable to modifiable haemodialysis practices in Sweden, Scand J Urol Nephrol, vol.44, issue.2, pp.113-133, 2010. ,
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study, Intern Emerg Med, vol.8, issue.5, pp.389-99, 2013. ,
, National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target, Am J Kidney Dis, vol.50, issue.3, pp.471-530, 2007.
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) Study, Nephrol Dial Transplant, vol.25, issue.9, pp.2846-50, 2010. ,
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol Dial Transplant, vol.19, issue.1, pp.121-153, 2004. ,
Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis, Am J Kidney Dis, vol.53, issue.3, pp.475-91, 2009. ,
, Department of Medical Informatics, 2014.
, Department of Medical Informatics, 2013.
QuaSi-Niere gGmbH, Bericht über Dialysebehandlung und Nierentransplantation in Deutschland, 2006. ,
, Società Italiana Nefrologia, 2011.
Long-term treatment with biosimilar epoetin-? (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study, Clin Nephrol, vol.89, p.109, 2018. ,
Risk-based individualisation of target Hb in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study), Int Urol Nephrol, vol.47, pp.837-882, 2015. ,
DOPPS-identified modifiable practices in haemodialysis (HD) patients in the European MONITOR-CKD5 (2010-12) study compared to DOPPS (2002-2003): significantly better quality of HD with disparities, Nephrol Dial Transplant, vol.28, issue.1, p.244, 2013. ,
Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy?: Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease, Kidney Int, vol.64, pp.92-100, 2003. ,
A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease, BMC Nephrol, vol.9, issue.2, pp.1-10, 2008. ,
Oral phosphate binders in patients with kidney failure, New Engl J Med, vol.362, issue.14, pp.1312-1336, 2010. ,
The challenge of controlling phosphorus in chronic kidney disease, Nephrol Dial Transplant, vol.31, pp.541-548, 2016. ,